263 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author임영효-
dc.date.accessioned2018-03-28T05:40:17Z-
dc.date.available2018-03-28T05:40:17Z-
dc.date.issued2014-11-
dc.identifier.citationNutrition, Metabolism and Cardiovascular Diseases, 2014, 24(11), P.1240-1245en_US
dc.identifier.issn0939-4753-
dc.identifier.issn1590-3729-
dc.identifier.urihttp://www.nmcd-journal.com/article/S0939-4753(14)00200-2/fulltext-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/53281-
dc.description.abstractBackgrounds and aims: C-reactive protein (CRP) levels predict incident and recurrent cardiovascular disease (CVD) events; however, associations between CRP and pre-clinical atherosclerosis is less certain. Since high concentrations of high-density lipoprotein cholesterol (HDL-C) are inversely associated with CVD risk, we investigated whether HDL-C modified the association between CRP concentration and measures of preclinical atherosclerosis. Methods and results: Data were analyzed from a Korean occupational cohort of 12,030 male subjects who underwent a cardiac computed tomography (CT) estimation of coronary artery calcification (CAC) score and an assessment of CVD risk factors. Logistic regression was used to describe associations between CRP and measures of pre-clinical atherosclerosis, such as CAC scores >0. As many as 1351 (11.2%) participants had a CAC score> 0. CRP was stratified into 3 groups based on clinical category: <1 mg/L, 1 to <2 mg/L, and >= 2 mg/dL. In the bottom CRP group, 907/8697 (10.4%) of subjects had a CAC score > 0, compared with 242/1943 (12.5%) in the middle group and 202/1396 (14.5%) in the top CRP group (p < 0.0001). After adjustment for multiple CVD risk factors, there was a positive association between CRP and CAC score> 0 (OR between top and bottom CRP groups, 1.41 [1.04, 1.90], p = 0.027) in the lowest HDL-C quartile but not in the highest HDL-C (OR between top and bottom CRP group, 0.80 [0.46, 1.39], p = 0.425). Conclusion: The association between CRP concentration and CAC score differed according to HDL-C levels. (C) 2014 Elsevier B.V. All rights reserved.en_US
dc.description.sponsorshipRobert S. Rosenson serves on advisory boards Aegerion, Amgen, F. Hoffman LaRoche, GSK, LipoScience, Novartis, Regeneron, and Sanofi. He is a stockholder in LipoScience. His institution receives research grants on his behalf from Amgen, Astra Zeneca, Eli Lilly, and Sanofi.en_US
dc.language.isoenen_US
dc.publisherElsevier Science B.V. Amsterdamen_US
dc.subjectHDL-C; CRPen_US
dc.subjectCoronary artery calcium (CAC) scoreen_US
dc.subjectAtherosclerosisen_US
dc.subjectCardio-metabolic risk factorsen_US
dc.subjectCardiovascular disease (CVD)en_US
dc.titleHDL-C levels modify the association between C-reactive protein and coronary artery calcium scoreen_US
dc.typeArticleen_US
dc.relation.no11-
dc.relation.volume24-
dc.identifier.doi10.1016/j.numecd.2014.06.003-
dc.relation.page1240-1245-
dc.relation.journalNUTRITION METABOLISM AND CARDIOVASCULAR DISEASES-
dc.contributor.googleauthorSung, K. C.-
dc.contributor.googleauthorCho, E. J.-
dc.contributor.googleauthorLim, Y. H.-
dc.contributor.googleauthorShin, J.-
dc.contributor.googleauthorPyun, W. B.-
dc.contributor.googleauthorKang, S. M.-
dc.contributor.googleauthorRosenson, R. S.-
dc.relation.code2014036925-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidmdoim-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE